Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses.
Publication
, Journal Article
Siddiqi, TJ; Cherney, D; Siddiqui, HF; Jafar, TH; Januzzi, JL; Khan, MS; Levin, A; Marx, N; Rangaswami, J; Testani, J; Usman, MS; Wanner, C ...
Published in: Journal of the American Society of Nephrology : JASN
February 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Journal of the American Society of Nephrology : JASN
DOI
EISSN
1533-3450
ISSN
1046-6673
Publication Date
February 2025
Volume
36
Issue
2
Start / End Page
242 / 255
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Siddiqi, T. J., Cherney, D., Siddiqui, H. F., Jafar, T. H., Januzzi, J. L., Khan, M. S., … Butler, J. (2025). Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses. Journal of the American Society of Nephrology : JASN, 36(2), 242–255. https://doi.org/10.1681/asn.0000000000000491
Siddiqi, Tariq Jamal, David Cherney, Hasan Fareed Siddiqui, Tazeen H. Jafar, James L. Januzzi, Muhammad Shahzeb Khan, Adeera Levin, et al. “Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses.” Journal of the American Society of Nephrology : JASN 36, no. 2 (February 2025): 242–55. https://doi.org/10.1681/asn.0000000000000491.
Siddiqi TJ, Cherney D, Siddiqui HF, Jafar TH, Januzzi JL, Khan MS, et al. Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses. Journal of the American Society of Nephrology : JASN. 2025 Feb;36(2):242–55.
Siddiqi, Tariq Jamal, et al. “Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses.” Journal of the American Society of Nephrology : JASN, vol. 36, no. 2, Feb. 2025, pp. 242–55. Epmc, doi:10.1681/asn.0000000000000491.
Siddiqi TJ, Cherney D, Siddiqui HF, Jafar TH, Januzzi JL, Khan MS, Levin A, Marx N, Rangaswami J, Testani J, Usman MS, Wanner C, Zannad F, Butler J. Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses. Journal of the American Society of Nephrology : JASN. 2025 Feb;36(2):242–255.
Published In
Journal of the American Society of Nephrology : JASN
DOI
EISSN
1533-3450
ISSN
1046-6673
Publication Date
February 2025
Volume
36
Issue
2
Start / End Page
242 / 255
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences